Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus

ClinicalTrials.gov ID: NCT00572559

Public ClinicalTrials.gov record NCT00572559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open Label, Multi-Center Clinical Trial, Comparing Microbiologic Response To Linezolid And Vancomycin In Ventilator-Associated Pneumonia (VAP) Due To Methicillin Resistant Staphylococcus Aureus (MRSA)

Study identification

NCT ID
NCT00572559
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
149 participants

Conditions and interventions

Interventions

  • Vancomycin Drug
  • Linezolid Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2002
Primary completion
Not listed
Completion
Dec 31, 2004
Last update posted
Jun 8, 2010

2002 – 2005

United States locations

U.S. sites
36
U.S. states
13
U.S. cities
25
Facility City State ZIP Site status
Pfizer Investigational Site Phoenix Arizona 85006
Pfizer Investigational Site Phoenix Arizona 85012
Pfizer Investigational Site Palm Springs California 92262
Pfizer Investigational Site Rancho Mirage California 92270
Pfizer Investigational Site Redlands California 92373
Pfizer Investigational Site Sacramento California 95819
Pfizer Investigational Site Sacramento California 95829
Pfizer Investigational Site Norwalk Connecticut 06850
Pfizer Investigational Site Waterbury Connecticut 06708
Pfizer Investigational Site Waterbury Connecticut 06721
Pfizer Investigational Site Augusta Georgia 30909
Pfizer Investigational Site Decatur Georgia 30033
Pfizer Investigational Site North East Atlanta Georgia 30308
Pfizer Investigational Site North East Atlanta Georgia 30322
Pfizer Investigational Site North East Atlanta Georgia 30329
Pfizer Investigational Site ‘Ewa Beach Hawaii 96706
Pfizer Investigational Site Chicago Illinois 60612
Pfizer Investigational Site Peoria Illinois 61603
Pfizer Investigational Site Peoria Illinois 61636
Pfizer Investigational Site Peoria Illinois 61637
Pfizer Investigational Site Lexington Kentucky 40536
Pfizer Investigational Site Louisville Kentucky 40206
Pfizer Investigational Site Buffalo New York 14215
Pfizer Investigational Site Cortland Manor New York 10567
Pfizer Investigational Site Jamaica New York 11418
Pfizer Investigational Site The Bronx New York 10467
Pfizer Investigational Site Cincinnati Ohio 45267-0559
Pfizer Investigational Site Memphis Tennessee 38103
Pfizer Investigational Site Memphis Tennessee 38104
Pfizer Investigational Site Memphis Tennessee 38163
Pfizer Investigational Site Nashville Tennessee 37212-3375
Pfizer Investigational Site Houston Texas 77030
Pfizer Investigational Site Spokane Washington 99204
Pfizer Investigational Site Spokane Washington 99216
Pfizer Investigational Site Spokane Washington 99220
Pfizer Investigational Site Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00572559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2010 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00572559 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →